...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: rumours have been flying around the last ...

couple years about a possible zen buyout. Is it fair to say that if any of the rumours had ever been true we should of or would of seen a SP rise/jump with the otc/grey market shares?

Share
New Message
Please login to post a reply